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The title compound, C12H13N3O, exists in an E conﬁguration
with respect to the C N bond [1.285 (2) A ˚ ]. The imidazole
ring forms a dihedral angle of 75.97 (10)  with the phenyl ring.
In the crystal, molecules are linked via O—H   N and C—
H   N hydrogen bonds into sheets lying parallel to (001). The
crystal structure also features C—H     interactions.
Related literature
For general background to and the pharmacological activities
of the title compound, see: Weinberg (1996); Wildfeuer et al.
(1998); Georgopapadakou (1998). For standard bond-length
data, see: Allen et al. (1987). For the stability of the
temperature controller used for the data collection, see:
Cosier & Glazer (1986).
Experimental
Crystal data
C12H13N3O
Mr = 215.25
Monoclinic, P21=c
a = 8.0990 (1) A ˚
b = 14.0513 (2) A ˚
c = 9.9771 (2) A ˚
  = 93.058 (1) 
V = 1133.79 (3) A ˚ 3
Z =4
Mo K  radiation
  = 0.08 mm
 1
T = 100 K
0.35   0.18   0.11 mm
Data collection
Bruker SMART APEXII CCD
diffractometer
Absorption correction: multi-scan
(SADABS; Bruker, 2009)
Tmin = 0.972, Tmax = 0.991
12642 measured reﬂections
3300 independent reﬂections
2653 reﬂections with I >2  (I)
Rint = 0.026
Reﬁnement
R[F
2 >2  (F
2)] = 0.065
wR(F
2) = 0.138
S = 1.13
3300 reﬂections
149 parameters
H atoms treated by a mixture of
independent and constrained
reﬁnement
 max = 0.36 e A ˚  3
 min =  0.29 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
Cg1 is the centroid of the C1–C6 phenyl ring.
D—H   AD —H H   AD    AD —H   A
O1—H1O1   N3
i 0.90 (3) 1.82 (3) 2.712 (2) 176 (3)
C2—H2A   N1
ii 0.95 2.56 3.477 (2) 162
C12—H12A   Cg1
iii 0.95 2.74 3.558 (2) 145
Symmetry codes: (i)  x þ 1;y þ 1
2; z þ 1
2; (ii)  x;y   1
2; z þ 1
2; (iii) x; y þ 1
2;z   3
2.
Data collection: APEX2 (Bruker, 2009); cell reﬁnement: SAINT
(Bruker, 2009); data reduction: SAINT; program(s) used to solve
structure: SHELXTL (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXTL; molecular graphics: SHELXTL; software used
to prepare material for publication: SHELXTL and PLATON (Spek,
2009).
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(E)-N-[3-(Imidazol-1-yl)-1-phenylpropylidene]hydroxylamine
Hoong-Kun Fun, Ching Kheng Quah, Mohamed I. Attia, Maha S. Almutairi and Soraya W. 
Ghoneim
Comment 
A significant increase in fungal infections has been observed over the past three decades. Many reports of invasive topical 
and systemic infections caused by the opportunistic pathogen Candida species are always associated with the use of 
broad-spectrum antibiotics, immunosuppressive agents, anticancer and anti-AIDS drugs (Weinberg, 1996). One of the 
major problems in the treatment of Candida infections is the spread of antifungal drug resistance mainly in patients 
chronically subjected to antimycotic therapy such as HIV-infected patients (Wildfeuer et al., 1998; Georgopapadakou, 
1998). Azoles are commonly used as antifungal agent specially for Candida infections as many marketed drugs contain 
the azole moiety. The title compound contains the azole moiety and it was prepared to test its antifungal potential and will 
be further elaborated to other azole-containing new bioactive chemical entities.
In the title compound, Fig.1, the imidazole ring (N2/N3/C10-C12, maximum deviation of 0.001 (2) Å at atoms N3, C11 
and C12) forms a dihedral angle of 75.97 (10)° with the phenyl ring (C1-C6). Bond lengths (Allen et al., 1987) and 
angles are within normal ranges. The title compound exists in trans configuration with respect to the C7═N1 bond 
[1.285 (2) Å].
In the crystal structure, Fig. 2, molecules are linked via intermolecular O1–H1O1···N3 and C2–H2A···N1 hydrogen 
bonds (Table 1) into two-dimensional networks parallel to (001). The crystal structure is further consolidated by C12–
H12A···Cg1iii (Table 1) interactions, where Cg1 is the centroid of C1-C6 phenyl ring.
Experimental 
A mixture of 3-(1H-imidazol-1-yl)-1-phenylpropan-1-one (0.02 g, 0.1 mmol), hydroxylamine hydrochloride (0.14 g, 0.2 
mol), and KOH (0.112 g, 0.2 mmol) in ethanol (10 ml) was refluxed under stirring for 18h. The reaction mixture was 
allowed to cool to room temperature and the insolubles were removed by filtration. The filtrate was evaporated under 
vacuum and the residue was suspended in water (10 ml), filtered, dried and recrystallized from ethanol to yield colourless 
blocks of the title compound.
Refinement 
Atom H1O1 was located in a difference Fourier map and refined freely with O1-H1O1 = 0.90 (3) Å. The remaining H 
atoms were positioned geometrically and refined using a riding model with C–H = 0.95 or 0.99 Å and Uiso(H) = 1.2 
Ueq(C).
Computing details 
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT (Bruker, 2009); data reduction: SAINT (Bruker, 2009); 
program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL 
(Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: supplementary materials
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SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).
Figure 1
The molecular structure of the title compound showing 50% probability displacement ellipsoids for non-H atoms. supplementary materials
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Figure 2
The crystal structure of the title compound, viewed along the b axis. H atoms not involved in hydrogen bonds (dashed 
lines) have been omitted for clarity. 
(E)-N-[3-(Imidazol-1-yl)-1-phenylpropylidene]hydroxylamine 
Crystal data 
C12H13N3O
Mr = 215.25
Monoclinic, P21/c
Hall symbol: -P 2ybc
a = 8.0990 (1) Å
b = 14.0513 (2) Å
c = 9.9771 (2) Å
β = 93.058 (1)°
V = 1133.79 (3) Å3
Z = 4
F(000) = 456
Dx = 1.261 Mg m−3
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 5276 reflections
θ = 2.5–30.1°
µ = 0.08 mm−1
T = 100 K
Block, colourless
0.35 × 0.18 × 0.11 mm
Data collection 
Bruker SMART APEXII CCD 
diffractometer
Radiation source: fine-focus sealed tube
Graphite monochromator
φ and ω scans
Absorption correction: multi-scan 
(SADABS; Bruker, 2009)
Tmin = 0.972, Tmax = 0.991
12642 measured reflections
3300 independent reflections
2653 reflections with I > 2σ(I)
Rint = 0.026
θmax = 30.2°, θmin = 2.5°
h = −9→11
k = −18→19
l = −14→14supplementary materials
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Refinement 
Refinement on F2
Least-squares matrix: full
R[F2 > 2σ(F2)] = 0.065
wR(F2) = 0.138
S = 1.13
3300 reflections
149 parameters
0 restraints
Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map
Hydrogen site location: inferred from 
neighbouring sites
H atoms treated by a mixture of independent 
and constrained refinement
w = 1/[σ2(Fo
2) + (0.0228P)2 + 1.5032P] 
where P = (Fo
2 + 2Fc
2)/3
(Δ/σ)max = 0.001
Δρmax = 0.36 e Å−3
Δρmin = −0.28 e Å−3
Special details 
Experimental. The crystal was placed in the cold stream of an Oxford Cryosystems Cobra open-flow nitrogen cryostat 
(Cosier & Glazer, 1986) operating at 100.0 (1) K.
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is 
used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based 
on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
xyz U iso*/Ueq
O1 0.35159 (18) 1.05298 (10) 0.16643 (14) 0.0222 (3)
N1 0.2389 (2) 1.00261 (11) 0.24156 (16) 0.0190 (3)
N2 0.37457 (19) 0.78810 (11) 0.03621 (15) 0.0155 (3)
N3 0.4790 (2) 0.66854 (12) 0.15734 (17) 0.0242 (4)
C1 −0.0041 (2) 0.79271 (13) 0.20420 (18) 0.0185 (4)
H1A 0.0470 0.7650 0.1301 0.022*
C2 −0.1123 (2) 0.73889 (14) 0.27705 (19) 0.0212 (4)
H2A −0.1339 0.6745 0.2529 0.025*
C3 −0.1888 (2) 0.77890 (14) 0.38485 (19) 0.0223 (4)
H3A −0.2612 0.7417 0.4354 0.027*
C4 −0.1592 (2) 0.87348 (14) 0.41854 (19) 0.0215 (4)
H4A −0.2131 0.9014 0.4911 0.026*
C5 −0.0509 (2) 0.92730 (14) 0.34644 (19) 0.0195 (4)
H5A −0.0313 0.9920 0.3700 0.023*
C6 0.0299 (2) 0.88731 (13) 0.23934 (18) 0.0154 (3)
C7 0.1555 (2) 0.94228 (12) 0.16866 (17) 0.0144 (3)
C8 0.1779 (2) 0.92702 (13) 0.02083 (18) 0.0164 (4)
H8A 0.1631 0.9888 −0.0259 0.020*
H8B 0.0896 0.8838 −0.0150 0.020*
C9 0.3457 (2) 0.88532 (13) −0.01285 (18) 0.0177 (4)
H9A 0.3536 0.8858 −0.1115 0.021*
H9B 0.4344 0.9270 0.0261 0.021*
C10 0.4732 (2) 0.76180 (14) 0.14318 (19) 0.0197 (4)supplementary materials
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H10A 0.5315 0.8053 0.2013 0.024*
C11 0.3783 (3) 0.63328 (14) 0.0532 (2) 0.0256 (4)
H11A 0.3577 0.5677 0.0365 0.031*
C12 0.3129 (3) 0.70599 (14) −0.0221 (2) 0.0233 (4)
H12A 0.2396 0.7011 −0.0994 0.028*
H1O1 0.403 (3) 1.0915 (19) 0.227 (3) 0.037 (7)*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
O1 0.0233 (7) 0.0180 (7) 0.0258 (7) −0.0076 (6) 0.0066 (6) −0.0048 (6)
N1 0.0181 (8) 0.0159 (7) 0.0232 (8) −0.0006 (6) 0.0033 (6) −0.0019 (6)
N2 0.0154 (7) 0.0140 (7) 0.0169 (7) 0.0004 (6) 0.0004 (6) −0.0012 (6)
N3 0.0239 (9) 0.0225 (9) 0.0261 (9) 0.0041 (7) 0.0016 (7) 0.0042 (7)
C1 0.0178 (9) 0.0193 (9) 0.0181 (8) −0.0008 (7) −0.0018 (7) −0.0015 (7)
C2 0.0223 (9) 0.0185 (9) 0.0221 (9) −0.0049 (7) −0.0049 (7) 0.0010 (7)
C3 0.0201 (9) 0.0263 (10) 0.0204 (9) −0.0036 (8) 0.0003 (7) 0.0064 (8)
C4 0.0199 (9) 0.0263 (10) 0.0185 (9) 0.0017 (8) 0.0023 (7) 0.0015 (7)
C5 0.0195 (9) 0.0184 (9) 0.0205 (9) 0.0012 (7) −0.0001 (7) −0.0014 (7)
C6 0.0143 (8) 0.0163 (8) 0.0149 (8) 0.0010 (7) −0.0041 (6) 0.0017 (6)
C7 0.0145 (8) 0.0121 (8) 0.0163 (8) 0.0038 (6) −0.0013 (6) 0.0021 (6)
C8 0.0176 (9) 0.0160 (8) 0.0152 (8) 0.0024 (7) −0.0021 (7) 0.0029 (6)
C9 0.0205 (9) 0.0148 (8) 0.0179 (8) 0.0014 (7) 0.0030 (7) 0.0021 (7)
C10 0.0207 (9) 0.0190 (9) 0.0191 (9) 0.0026 (7) −0.0017 (7) −0.0009 (7)
C11 0.0258 (10) 0.0177 (9) 0.0338 (11) −0.0002 (8) 0.0057 (9) −0.0026 (8)
C12 0.0252 (10) 0.0197 (9) 0.0244 (9) −0.0019 (8) −0.0044 (8) −0.0043 (8)
Geometric parameters (Å, º) 
O1—N1 1.403 (2) C4—C5 1.388 (3)
O1—H1O1 0.90 (3) C4—H4A 0.9500
N1—C7 1.285 (2) C5—C6 1.400 (3)
N2—C10 1.350 (2) C5—H5A 0.9500
N2—C12 1.374 (2) C6—C7 1.485 (3)
N2—C9 1.466 (2) C7—C8 1.511 (2)
N3—C10 1.319 (3) C8—C9 1.534 (3)
N3—C11 1.378 (3) C8—H8A 0.9900
C1—C2 1.391 (3) C8—H8B 0.9900
C1—C6 1.398 (3) C9—H9A 0.9900
C1—H1A 0.9500 C9—H9B 0.9900
C2—C3 1.389 (3) C10—H10A 0.9500
C2—H2A 0.9500 C11—C12 1.359 (3)
C3—C4 1.389 (3) C11—H11A 0.9500
C3—H3A 0.9500 C12—H12A 0.9500
N1—O1—H1O1 103.3 (17) N1—C7—C6 115.28 (16)
C7—N1—O1 111.57 (15) N1—C7—C8 124.02 (17)
C10—N2—C12 106.95 (16) C6—C7—C8 120.70 (15)
C10—N2—C9 126.60 (15) C7—C8—C9 114.95 (15)
C12—N2—C9 126.38 (16) C7—C8—H8A 108.5supplementary materials
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C10—N3—C11 105.09 (17) C9—C8—H8A 108.5
C2—C1—C6 120.45 (18) C7—C8—H8B 108.5
C2—C1—H1A 119.8 C9—C8—H8B 108.5
C6—C1—H1A 119.8 H8A—C8—H8B 107.5
C3—C2—C1 120.27 (18) N2—C9—C8 114.23 (15)
C3—C2—H2A 119.9 N2—C9—H9A 108.7
C1—C2—H2A 119.9 C8—C9—H9A 108.7
C4—C3—C2 119.75 (18) N2—C9—H9B 108.7
C4—C3—H3A 120.1 C8—C9—H9B 108.7
C2—C3—H3A 120.1 H9A—C9—H9B 107.6
C5—C4—C3 120.14 (18) N3—C10—N2 111.89 (17)
C5—C4—H4A 119.9 N3—C10—H10A 124.1
C3—C4—H4A 119.9 N2—C10—H10A 124.1
C4—C5—C6 120.72 (18) C12—C11—N3 110.14 (18)
C4—C5—H5A 119.6 C12—C11—H11A 124.9
C6—C5—H5A 119.6 N3—C11—H11A 124.9
C1—C6—C5 118.63 (17) C11—C12—N2 105.94 (17)
C1—C6—C7 120.40 (16) C11—C12—H12A 127.0
C5—C6—C7 120.90 (16) N2—C12—H12A 127.0
C6—C1—C2—C3 0.5 (3) C5—C6—C7—C8 −147.91 (17)
C1—C2—C3—C4 1.1 (3) N1—C7—C8—C9 66.1 (2)
C2—C3—C4—C5 −1.3 (3) C6—C7—C8—C9 −114.85 (18)
C3—C4—C5—C6 −0.1 (3) C10—N2—C9—C8 −104.3 (2)
C2—C1—C6—C5 −1.9 (3) C12—N2—C9—C8 79.3 (2)
C2—C1—C6—C7 175.03 (17) C7—C8—C9—N2 65.6 (2)
C4—C5—C6—C1 1.7 (3) C11—N3—C10—N2 0.1 (2)
C4—C5—C6—C7 −175.24 (17) C12—N2—C10—N3 0.0 (2)
O1—N1—C7—C6 −178.52 (14) C9—N2—C10—N3 −176.95 (17)
O1—N1—C7—C8 0.6 (2) C10—N3—C11—C12 −0.1 (2)
C1—C6—C7—N1 −145.59 (17) N3—C11—C12—N2 0.1 (2)
C5—C6—C7—N1 31.3 (2) C10—N2—C12—C11 −0.1 (2)
C1—C6—C7—C8 35.2 (2) C9—N2—C12—C11 176.87 (18)
Hydrogen-bond geometry (Å, º) 
Cg1 is the centroid of the C1–C6 phenyl ring.
D—H···AD —H H···AD ···AD —H···A
O1—H1O1···N3i 0.90 (3) 1.82 (3) 2.712 (2) 176 (3)
C2—H2A···N1ii 0.95 2.56 3.477 (2) 162
C12—H12A···Cg1iii 0.95 2.74 3.558 (2) 145
Symmetry codes: (i) −x+1, y+1/2, −z+1/2; (ii) −x, y−1/2, −z+1/2; (iii) x, −y+1/2, z−3/2.